Phathom Pharmaceuticals (PHAT) Equity Ratio (2022 - 2025)
Historic Equity Ratio for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Q3 2025 value amounting to 1.76.
- Phathom Pharmaceuticals' Equity Ratio fell 26373.62% to 1.76 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.76, marking a year-over-year decrease of 26373.62%. This contributed to the annual value of 0.67 for FY2024, which is 28124.65% down from last year.
- As of Q3 2025, Phathom Pharmaceuticals' Equity Ratio stood at 1.76, which was down 26373.62% from 1.62 recorded in Q2 2025.
- Over the past 5 years, Phathom Pharmaceuticals' Equity Ratio peaked at 0.26 during Q1 2022, and registered a low of 1.76 during Q3 2025.
- For the 4-year period, Phathom Pharmaceuticals' Equity Ratio averaged around 0.53, with its median value being 0.45 (2022).
- Its Equity Ratio has fluctuated over the past 5 years, first soared by 30253.81% in 2023, then tumbled by 120253.71% in 2024.
- Phathom Pharmaceuticals' Equity Ratio (Quarter) stood at 0.45 in 2022, then skyrocketed by 61.27% to 0.18 in 2023, then crashed by 281.25% to 0.67 in 2024, then crashed by 162.34% to 1.76 in 2025.
- Its Equity Ratio was 1.76 in Q3 2025, compared to 1.62 in Q2 2025 and 1.15 in Q1 2025.